The relevance of RXRα in cancer is well-established as genetic disruption of RXRα can promote tumorigenesis (96) and RXRα binding to PML/RAR is necessary for the development of acute promyelocytic leukemia (97). This evidence concerns the gene RXRA and acute promyelocytic leukemia.